STRUCTURAL BASED DESIGN OF IL-17 DOMINANT NEGATIVE MUTANTS

摘要

IL-17 Receptor binding proteins, including non-naturally occurring and recombinantly modified proteins, methods of making and using such molecules as therapeutic, prophylactic and diagnostic agents are provided.